DS

Donna Skerrett

Dr Skerrett has more than 30 years of experience in transfusion medicine, cellular therapy, and transplantation. She brings experience in medical, clinical, and regulatory affairs. Donna served previously as Chief Medical Officer at Mesoblast. She was Director of Transfusion Medicine and Cellular Therapy at Weill Cornell Medical Center in New York (2004 - 2011), and prior to that was Associate Director of Transfusion Medicine and Director of Stem Cell Facilities at Columbia University's New York-Presbyterian Hospital. She has previously chaired the New York State Council on Blood and Transfusion Services, and served on the Board of Directors of the Fox Chase Cancer Center in Philadelphia, PA and is currently a member of the Board of Visitors of Lewis Katz School of Medicine at Temple University.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
30/06/241,094,284N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
22/10/24
Expiry
1,000,000$0.215$215,000As advised by the company
29/02/24
Issued
1,000,000$0.350$350,000As advised by the company
25/01/22
Buy
375,000$1.890$708,750As advised by the company
19/11/20
Buy
500,000$3.050$1,525,000As advised by the company